Top five ways to reduce cancer risk

submitted by: mdanderson

You can reduce your cancer risk by following these simple guidelines from Ernest Hawk, M.D., vice president of Cancer Prevention and Population Sciences at MD Anderson Cancer Center. Many diseases can be avoided by changing your lifestyle. Learn what you can reduce your risk for cancer.

Cognitive Heart Failure explained via 3D Animation

submitted by: Scientific Animations

CHF or Congestive Heart Failure, a condition on continuos rise explained - Are lifestyle changes responsible for increase in cases of CHF? What are the main causes? Economic impact on health system? Innovations in diagnosing and treating CHF?
Medical Industry Trends for CHF

Oct 2, 2014; Informatics Journal Club Webinar; Hua Xu

submitted by: ucsd_idash
Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality Hua Xu, Melinda C Aldrich, Qingxia Chen, Hongfang Liu, Neeraja B Peterson, Qi Dai, Mia Levy, Anushi Shah, Xue Han, Xiaoyang Ruan, Min Jiang, Ying Li, Jamii St Julien, Jeremy Warner, Carol Friedman, Dan M Roden, Joshua C Denny J Am Med Inform Assoc Published Online First: 22 July 201 doi:10.1136/amiajnl-2014-002649 Hua Xu The University of Texas...

Microbial signature profiles of periodontally healthy and diseased patients

submitted by: apcolombo
Aim: To determine microbial profiles that discriminate periodontal health from different forms of periodontal diseases. Methods: Subgingival biofilm was obtained from patients with periodontal health (27), gingivitis (11), chronic periodontitis (35) and aggressive periodontitis (24), and analysed for the presence of >250 species/phylotypes using HOMIM. Microbial differences among groups were examined by Mann–Whitney U-test. Regression analyses were performed to determine microbial...
Authors: Talita Lourenço, Debora Heller, Carina Silva-Boghossian, Sean Cotton, Bruce Paster, Ana Paula Colombo

Breakthrough Therapies for Idiopathic Pulmonary Fibrosis

submitted by: mcgheek

Timothy P.M. Whelan, M.D., Medical Director of the Lung Transplant Program at the Medical University of South Carolina, discusses promising clinical trial results of new agents (pirfenidone, nintedanib) for the treatment of idiopathic pulmonary fibrosis (IPF). To date, only supportive care and transplant (for eligible patients) have been available to IPF patients, but these new trial results could lead to FDA approval of the first drugs for IPF.

NCAR study points to increase in unhealthy summertime ozone levels

submitted by: nsf

Local weather forecast warnings about unhealthy air could become much more common around the country. A recent scientific study by the National Center for Atmospheric Research warns of a whopping 70% increase in the number of days with unhealthy summertime ozone levels by the year 2050.